Mouse monoclonal antibodies used in this study
Antigen/specificity | Clone | Ig chain | Supplier | Concentration |
Dendritic cell markers: | ||||
CD35 (CR1, DRC-1) | Ber-MAC-DRC | IgG | Dako | 1/50 |
CD29 (β1) | 4B4LDC9LDH8 | IgG1 | Coulter | 1/50 |
CD49b (α2, VLA-2 α) | P1E6 | IgG1 | Dako | 1/50 |
CD49c (α3, VLA-3 α) | P1B5 | IgG1 | Dako | 1/50 |
CD18 (β2 integrin) | MHM23 | IgG1 | Dako | 1/50 |
CD11a (αL, LFA-1 α) | MHM24 | IgG1 | Dako | 1/50 |
CD11b (αM, C3biR α) | 2LPM19c | IgG1 | Dako | 1/50 |
CD11c (αX, p150.95) | SHCL3 | IgG2b | Dako | 1/50 |
VCAM-1 (CD106) | 1G11 | IgG1 | Immunotech | 1/50 |
VCAM-1 (SD106) | 2G7 | IgG1 | Otsuka Pharmaceutical | 1/100 |
CD14 | 116 | IgM | Coulter | 1/50 |
Class II-MHC(HLA-DR) | L243 | IgG2a | Becton Dickinson | 1/20 |
Class I-MHC | W6/32 | IgG2 | Dako | 1/50 |
ICAM-1 (CD54) | LB-2 | IgG2b | Becton Dickinson | 1/20 |
DRC-1, dendritic reticulum cell-1 marker (CD35); CD35 (CR-1), complement-3 receptor-1; CD11b (CR-3), complement-3 receptor-3; α2, α3: integrins of β1 integrin family; αX, αM: integrins of β2 family; VCAM-1, vascular cell adhesion molecule-1 (CD106).